Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2024 |
| Outros Autores: | , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| Texto Completo: | http://hdl.handle.net/10362/174214 |
Resumo: | The authors acknowledge the support from FCT/MCTES through the projects PTDC/EQU/EPR/119631/2010. The authors wish to thank the Analytical Services Laboratory of REQUIMTE for providing the DSC results. Publisher Copyright: © 2024 by the authors. |
| id |
RCAP_d0d82102e24f99d8e9aca97b2f9e8709 |
|---|---|
| oai_identifier_str |
oai:run.unl.pt:10362/174214 |
| network_acronym_str |
RCAP |
| network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| repository_id_str |
https://opendoar.ac.uk/repository/7160 |
| spelling |
Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG NanoparticlesBaker–Lonsdale modeldoxorubicindrug-controlled releasenanoparticlesPLGAPLGA-PEG copolymersMaterials Science(all)Condensed Matter PhysicsSDG 3 - Good Health and Well-beingThe authors acknowledge the support from FCT/MCTES through the projects PTDC/EQU/EPR/119631/2010. The authors wish to thank the Analytical Services Laboratory of REQUIMTE for providing the DSC results. Publisher Copyright: © 2024 by the authors.Nanoparticles (NPs) have become attractive vehicles for drug delivery in cancer therapy due to their ability to accumulate in tumours and mitigate side effects. This study focuses on the production of doxorubicin (DOX)-loaded NPs comprising Poly (lactic-co-glycolic acid)-Polyethylene glycol with varying PEG proportions and the examination of their impact on drug release kinetics. DOX-loaded NPs, composed of PLGA-co-PEG with PEG contents of 0%, 5%, 10%, and 15%, were synthesized by the solvent evaporation technique, exhibited spherical morphology, and had sizes ranging from 420 nm to 690 nm. In vitro drug release studies revealed biphasic profiles, with higher PEG contents leading to faster and more extensive drug release. The Baker–Lonsdale model demonstrated the best fit to the drug release data, indicating that the release process is diffusion-controlled. The diffusion coefficients for DOX determined ranged from 6.3 × 10−18 to 7.55 × 10−17 cm2s−1 and exhibited an upward trend with increasing PEG content in the polymer. In vitro cytotoxicity tests with CHO cells showed that unloaded NPs are non-toxic, while DOX-loaded PLGA-PEG 15% NPs induced a greater decrease in cellular viability compared to their PLGA counterparts. A mathematical relationship between the diffusion coefficient and PEG percentage was derived, providing a practical tool for optimizing DOX release profiles.LAQV@REQUIMTEDQ - Departamento de QuímicaRUNCardoso, Maria MargaridaPeça, Inês N.Bicho, Ana2024-10-29T00:37:52Z2024-07-172024-07-17T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article11application/pdfhttp://hdl.handle.net/10362/174214engCardoso, M. M., Peça, I. N., & Bicho, A. (2024). Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles. Materials, 17(14), Article 3544. https://doi.org/10.3390/ma171435441996-1944PURE: 101113409https://doi.org/10.3390/ma17143544info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-01-20T01:37:00Zoai:run.unl.pt:10362/174214Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T19:12:36.452815Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
| dc.title.none.fl_str_mv |
Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles |
| title |
Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles |
| spellingShingle |
Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles Cardoso, Maria Margarida Baker–Lonsdale model doxorubicin drug-controlled release nanoparticles PLGA PLGA-PEG copolymers Materials Science(all) Condensed Matter Physics SDG 3 - Good Health and Well-being |
| title_short |
Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles |
| title_full |
Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles |
| title_fullStr |
Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles |
| title_full_unstemmed |
Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles |
| title_sort |
Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles |
| author |
Cardoso, Maria Margarida |
| author_facet |
Cardoso, Maria Margarida Peça, Inês N. Bicho, Ana |
| author_role |
author |
| author2 |
Peça, Inês N. Bicho, Ana |
| author2_role |
author author |
| dc.contributor.none.fl_str_mv |
LAQV@REQUIMTE DQ - Departamento de Química RUN |
| dc.contributor.author.fl_str_mv |
Cardoso, Maria Margarida Peça, Inês N. Bicho, Ana |
| dc.subject.por.fl_str_mv |
Baker–Lonsdale model doxorubicin drug-controlled release nanoparticles PLGA PLGA-PEG copolymers Materials Science(all) Condensed Matter Physics SDG 3 - Good Health and Well-being |
| topic |
Baker–Lonsdale model doxorubicin drug-controlled release nanoparticles PLGA PLGA-PEG copolymers Materials Science(all) Condensed Matter Physics SDG 3 - Good Health and Well-being |
| description |
The authors acknowledge the support from FCT/MCTES through the projects PTDC/EQU/EPR/119631/2010. The authors wish to thank the Analytical Services Laboratory of REQUIMTE for providing the DSC results. Publisher Copyright: © 2024 by the authors. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024-10-29T00:37:52Z 2024-07-17 2024-07-17T00:00:00Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/174214 |
| url |
http://hdl.handle.net/10362/174214 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
Cardoso, M. M., Peça, I. N., & Bicho, A. (2024). Impact of PEG Content on Doxorubicin Release from PLGA-co-PEG Nanoparticles. Materials, 17(14), Article 3544. https://doi.org/10.3390/ma17143544 1996-1944 PURE: 101113409 https://doi.org/10.3390/ma17143544 |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
11 application/pdf |
| dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
| instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
| instacron_str |
RCAAP |
| institution |
RCAAP |
| reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
| repository.mail.fl_str_mv |
info@rcaap.pt |
| _version_ |
1833597942867427328 |